About Stephen M. Bravo

My role on the Calyx Executive Leadership team enables me to bring my extensive experience in Neuroradiology, Musculoskeletal Radiology, and Interventional Radiology to the organization’s scientific, medical, and clinical teams. Together, we are optimizing imaging processes and outcomes to accelerate the development of new medical treatments – a mission that is near and dear to me. For example, we routinely advise our biopharmaceutical clients on the use of imaging biomarkers and choosing the best image acquisition strategy and technology to help them meet their clinical development objectives.

Having served as a board-certified diagnostic radiologist at highly acclaimed healthcare centers including Brigham and Women’s Hospital, as a faculty member at leading academic institutions such as Harvard Medical School, and an investigator on over 100 pharmaceutical, non-pharmaceutical, and government-funded research projects, I fully understand the needs of our customers’ clients (prescribers). This begins with ways to use technology to increase the scientific rigor of trials and extends to talking with pharma CMOs about the best ways to commercialize their products and overcome obstacles to reimbursement and adoption.